{"title":"肺炎克雷伯菌肝脓肿患者侵袭性综合征预测模型的建立和验证。","authors":"Liyong Zhang, Jiaqi Chen, Yihao Qu, Xidong Cao, Jinhua Cui, Jian Li, Aijun Yu","doi":"10.3389/fmed.2025.1663407","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Pyogenic liver abscess (PLA) is a life-threatening liver bacterial infection causing suppurative lesions. In Asia, hypervirulent <i>Klebsiella pneumoniae</i> (hvKP) is the main PLA pathogen, linked to invasive syndromes. Severe <i>Klebsiella pneumoniae</i> liver abscess (KPLA) manifestations, called invasive KPLA syndrome (IKPLAS), have acute onset, rapid progression and non-specific symptoms, often leading to poor prognosis if untreated. This study aimed to find risk factors and create a validated nomogram for predicting invasive syndrome in KPLA patients.</p><p><strong>Methods: </strong>We retrospectively analyzed clinical data from 529 KPLA patients treated at Chengde Medical University Affiliated Hospital between August 1, 2014, and November 30, 2024. By using the 7:3 stratified random sampling method, the patients were assigned to two cohorts: derivation (<i>n</i> = 370) and validation (<i>n</i> = 159). Univariate and multivariate logistic regression analyses were performed to identify risk factors for invasive KPLA syndrome (IKPLAS). A predictive nomogram was constructed and evaluated for discrimination and clinical utility.</p><p><strong>Results: </strong>Of the 529 enrolled patients, 33 patients (6.2%) developed IKPLAS (IKPLAS group), while the remaining 496 patients were included in the non-invasive group (NIKPLAS group). Both groups showed significant differences (<i>P</i> < 0.05) in the incidence of viral hepatitis, biliary disease, type 2 diabetes mellitus (T2DM), vomiting, pulmonary infection, and septic shock; C-reactive protein level; abscess diameter; presence of a gas-containing abscess; and Sequential Organ Failure Assessment (SOFA) score. Multivariate analysis identified the following factors as independent predictors: viral hepatitis, T2DM, abscess diameter, presence of a gas-containing abscess, and SOFA score. The nomogram showed excellent calibration (Hosmer-Lemeshow χ<sup>2</sup> = 4.171, <i>P</i> = 0.841) with area under the receiver operating characteristic curve values of 0.961 (derivation cohort) and 0.899 (validation cohort). The clinical utility of the nomogram was confirmed by decision curve analysis.</p><p><strong>Conclusion: </strong>Viral hepatitis, T2DM, abscess diameter, presence of a gas-containing abscess, and SOFA score are the predictive factors of IKPLAS. The developed nomogram provides reliable risk stratification for patients with KPLA and can be applied clinically to predict IKPLAS cases.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1663407"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12488649/pdf/","citationCount":"0","resultStr":"{\"title\":\"Development and validation of a predictive model for invasive syndrome in patients with <i>Klebsiella pneumoniae</i> liver abscess.\",\"authors\":\"Liyong Zhang, Jiaqi Chen, Yihao Qu, Xidong Cao, Jinhua Cui, Jian Li, Aijun Yu\",\"doi\":\"10.3389/fmed.2025.1663407\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Pyogenic liver abscess (PLA) is a life-threatening liver bacterial infection causing suppurative lesions. In Asia, hypervirulent <i>Klebsiella pneumoniae</i> (hvKP) is the main PLA pathogen, linked to invasive syndromes. Severe <i>Klebsiella pneumoniae</i> liver abscess (KPLA) manifestations, called invasive KPLA syndrome (IKPLAS), have acute onset, rapid progression and non-specific symptoms, often leading to poor prognosis if untreated. This study aimed to find risk factors and create a validated nomogram for predicting invasive syndrome in KPLA patients.</p><p><strong>Methods: </strong>We retrospectively analyzed clinical data from 529 KPLA patients treated at Chengde Medical University Affiliated Hospital between August 1, 2014, and November 30, 2024. By using the 7:3 stratified random sampling method, the patients were assigned to two cohorts: derivation (<i>n</i> = 370) and validation (<i>n</i> = 159). Univariate and multivariate logistic regression analyses were performed to identify risk factors for invasive KPLA syndrome (IKPLAS). A predictive nomogram was constructed and evaluated for discrimination and clinical utility.</p><p><strong>Results: </strong>Of the 529 enrolled patients, 33 patients (6.2%) developed IKPLAS (IKPLAS group), while the remaining 496 patients were included in the non-invasive group (NIKPLAS group). Both groups showed significant differences (<i>P</i> < 0.05) in the incidence of viral hepatitis, biliary disease, type 2 diabetes mellitus (T2DM), vomiting, pulmonary infection, and septic shock; C-reactive protein level; abscess diameter; presence of a gas-containing abscess; and Sequential Organ Failure Assessment (SOFA) score. Multivariate analysis identified the following factors as independent predictors: viral hepatitis, T2DM, abscess diameter, presence of a gas-containing abscess, and SOFA score. The nomogram showed excellent calibration (Hosmer-Lemeshow χ<sup>2</sup> = 4.171, <i>P</i> = 0.841) with area under the receiver operating characteristic curve values of 0.961 (derivation cohort) and 0.899 (validation cohort). The clinical utility of the nomogram was confirmed by decision curve analysis.</p><p><strong>Conclusion: </strong>Viral hepatitis, T2DM, abscess diameter, presence of a gas-containing abscess, and SOFA score are the predictive factors of IKPLAS. The developed nomogram provides reliable risk stratification for patients with KPLA and can be applied clinically to predict IKPLAS cases.</p>\",\"PeriodicalId\":12488,\"journal\":{\"name\":\"Frontiers in Medicine\",\"volume\":\"12 \",\"pages\":\"1663407\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-09-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12488649/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fmed.2025.1663407\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1663407","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Development and validation of a predictive model for invasive syndrome in patients with Klebsiella pneumoniae liver abscess.
Introduction: Pyogenic liver abscess (PLA) is a life-threatening liver bacterial infection causing suppurative lesions. In Asia, hypervirulent Klebsiella pneumoniae (hvKP) is the main PLA pathogen, linked to invasive syndromes. Severe Klebsiella pneumoniae liver abscess (KPLA) manifestations, called invasive KPLA syndrome (IKPLAS), have acute onset, rapid progression and non-specific symptoms, often leading to poor prognosis if untreated. This study aimed to find risk factors and create a validated nomogram for predicting invasive syndrome in KPLA patients.
Methods: We retrospectively analyzed clinical data from 529 KPLA patients treated at Chengde Medical University Affiliated Hospital between August 1, 2014, and November 30, 2024. By using the 7:3 stratified random sampling method, the patients were assigned to two cohorts: derivation (n = 370) and validation (n = 159). Univariate and multivariate logistic regression analyses were performed to identify risk factors for invasive KPLA syndrome (IKPLAS). A predictive nomogram was constructed and evaluated for discrimination and clinical utility.
Results: Of the 529 enrolled patients, 33 patients (6.2%) developed IKPLAS (IKPLAS group), while the remaining 496 patients were included in the non-invasive group (NIKPLAS group). Both groups showed significant differences (P < 0.05) in the incidence of viral hepatitis, biliary disease, type 2 diabetes mellitus (T2DM), vomiting, pulmonary infection, and septic shock; C-reactive protein level; abscess diameter; presence of a gas-containing abscess; and Sequential Organ Failure Assessment (SOFA) score. Multivariate analysis identified the following factors as independent predictors: viral hepatitis, T2DM, abscess diameter, presence of a gas-containing abscess, and SOFA score. The nomogram showed excellent calibration (Hosmer-Lemeshow χ2 = 4.171, P = 0.841) with area under the receiver operating characteristic curve values of 0.961 (derivation cohort) and 0.899 (validation cohort). The clinical utility of the nomogram was confirmed by decision curve analysis.
Conclusion: Viral hepatitis, T2DM, abscess diameter, presence of a gas-containing abscess, and SOFA score are the predictive factors of IKPLAS. The developed nomogram provides reliable risk stratification for patients with KPLA and can be applied clinically to predict IKPLAS cases.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world